loading page

Risk Factors for Maternal Death in an Urban Tertiary Hospital in Kenya: A Case-Cohort Study
  • +7
  • Moses Ndiritu,
  • Magoma Mwancha-Kwasa,
  • Rashida Admani,
  • Margaret Mbugua,
  • Patrick Nyaga,
  • Prabhjot Juttla,
  • Teresia Njoki Kimani,
  • Ryan Gitau,
  • Alfred Owino Odongo,
  • Mary Maina
Moses Ndiritu
Kenya Ministry of Health

Corresponding Author:[email protected]

Author Profile
Magoma Mwancha-Kwasa
Kenya Ministry of Health
Author Profile
Rashida Admani
Kenya Ministry of Health
Author Profile
Margaret Mbugua
Kenya Ministry of Health
Author Profile
Patrick Nyaga
Kenya Ministry of Health
Author Profile
Prabhjot Juttla
Kenya Ministry of Health
Author Profile
Teresia Njoki Kimani
Kenya Ministry of Health
Author Profile
Ryan Gitau
Kenya Ministry of Health
Author Profile
Alfred Owino Odongo
Mount Kenya University
Author Profile
Mary Maina
Kenya Ministry of Health
Author Profile

Abstract

Objective: To evaluate the risk of maternal death following the intensification of Maternal and Perinatal Death Surveillance (MPDSR) activities and the substitution of dinoprostone for misoprostol for labour induction. Design: Case-cohort Setting: Kiambu County Referral Hospital(KCRH), Kiambu County, Kenya Population or Sample: Mothers delivering at KCRH during January 2018 - December 2021 Methods: We recruited all 58 mothers who died between January 2018 and December 2021 as cases. A random subcohort of 232 mothers who did not die was selected from a retrospective cohort study of 411 mothers as controls. Multiple logistic regression was used to model the determinants of maternal mortality adjusted for intensified MPDSR activities and labour induction agents. Main Outcome Measures: Adjusted odds ratio of maternal mortality for mothers induced with misoprostol versus dinoprostone and for delivery prior to and after the intensification of MPDSR activities. Results: Factors associated with increased risk maternal mortality included: unemployment (AOR 1.83; 95% C.I.: 0.52 – 7.50), singlehood (AOR 3.47; 95% C.I.: 0.59 – 17.9), labour induction with misoprostol (AOR 7.17; 95% C.I.: 0.72 - 182), multiparity (AOR 3.11; 95% C.I.: 1.37 – 6.98, p = 0.006), or being pre-term (AOR 4.79; 95% C.I.: 1.56 – 15.7, p = 0.007). Conclusions: The risk of maternal mortality did not decrease with the intensification of MPDSR activities but increased with the use of misoprostol to induce labour. Funding: Ministry of Health (Kenya), Transforming Health for Universal Health Coverage